APS Stroke in SLE — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Antiphospholipid syndrome
Arterial thrombosis (stroke) in a patient with known triple-positive APS on subtherapeutic warfarin. APS is the most common cause of acquired thrombophilia in SLE. Subtherapeutic INR allowed thrombosis. Management is therapeutic anticoagulation with warfarin (target INR 2.0–3.0 or higher). DOACs are contraindicated in triple-positive APS.
Reference: EULAR – 2019 – APS Guidelines; Stroke Foundation 2024